Advances in Urologic Imaging Prostate-Specific Membrane Antigen Ligand PET Imaging

被引：30
|
作者：
Hofman, Michael S. [1 ,2 ]
Iravani, Amir [1 ]
Nzenza, Tatenda [3 ,4 ]
Murphy, Declan G. [3 ]
机构：
[1] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Dept Canc Imaging, 305 Grattan St, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, 305 Grattan St, Melbourne, Vic 3000, Australia
[3] Univ Melbourne, Sir Peter MacCallum Dept Surg Oncol, 305 Grattan St, Melbourne, Vic 3000, Australia
[4] Austin Hosp, 305 Grattan St, Melbourne, Vic 3000, Australia
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2018年 / 45卷 / 03期
关键词：
Prostate cancer; Prostate-specific membrane antigen; PET; PSMA PET/CT; PSMA PET; EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY; SMALL-MOLECULE INHIBITORS; MONOCLONAL-ANTIBODY J591; ESTRO-SIOG GUIDELINES; LYMPH-NODE DISSECTION; PART II TREATMENT; RADIATION-DOSIMETRY; MAGNETIC-RESONANCE; GA-68-PSMA PET/CT; BIOCHEMICAL RECURRENCE;
D O I：
10.1016/j.ucl.2018.03.016
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Radiolabeled prostate-specific membrane antigen (PSMA) PET is emerging as an important modality for imaging prostate cancer (PCa). Promising clinical experience has led to increasing number of studies exploring the role of PSMA PET in different aspects of PCa, including primary detection, risk stratification, targeted biopsy, initial staging, restaging at biochemical recurrence, biologic characterization, treatment response assessment, and prognostication. PSMA PET may prove an important disease biomarker, expand our understanding of the pathogenesis, and pave the way for personalized management of PCa.
引用
收藏
页码：503 / +
页数：23
相关论文
共 50 条
  • [21] PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
    Rowe, S. P.
    Gorin, M. A.
    Allaf, M. E.
    Pienta, K. J.
    Iran, P. T.
    Pomper, M. G.
    Ross, A. E.
    Cho, S. Y.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (03) : 223 - 230
  • [22] Research progress on prostate-specific membrane antigen ligand positron emission tomography imaging of prostate cancer
    Li Y.
    Liu B.
    Yuan Y.
    Qin W.
    Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 2022, 39 (06): : 1263 - 1268
  • [23] Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls
    Sheikhbahaei, Sara
    Werner, Rudolf A.
    Solnes, Lilja B.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Gorin, Michael A.
    Rowe, Steven P.
    SEMINARS IN NUCLEAR MEDICINE, 2019, 49 (04) : 255 - 270
  • [24] 64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
    Banerjee, Sangeeta Ray
    Pullambhatla, Mrudula
    Foss, Catherine A.
    Nimmagadda, Sridhar
    Ferdani, Riccardo
    Anderson, Carolyn J.
    Mease, Ronnie C.
    Pomper, Martin G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2657 - 2669
  • [25] PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
    S P Rowe
    M A Gorin
    M E Allaf
    K J Pienta
    P T Tran
    M G Pomper
    A E Ross
    S Y Cho
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 223 - 230
  • [26] Prostate-specific membrane antigen as a target for cancer imaging and therapy
    Kiess, A. P.
    Banerjee, S. R.
    Mease, R. C.
    Rowe, S. P.
    Rao, A.
    Foss, C. A.
    Chen, Y.
    Yang, X.
    Cho, S. Y.
    Nimmagadda, S.
    Pomper, M. G.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (03): : 241 - 268
  • [27] Prostate-specific Membrane Antigen PET in Prostate Cancer
    Lawhn-Heath, Courtney
    Salavati, Ali
    Behr, Spencer C.
    Rowe, Steven P.
    Calais, Jeremie
    Fendler, Wolfgang P.
    Eiber, Mattias
    Emmett, Louise
    Hofman, Michael S.
    Hope, Thomas A.
    RADIOLOGY, 2021, 299 (02) : 248 - 260
  • [28] Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
    Sara Sheikhbahaei
    Ali Afshar-Oromieh
    Matthias Eiber
    Lilja B. Solnes
    Mehrbod S. Javadi
    Ashley E. Ross
    Kenneth J. Pienta
    Mohamad E. Allaf
    Uwe Haberkorn
    Martin G. Pomper
    Michael A. Gorin
    Steven P. Rowe
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 2117 - 2136
  • [29] PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study
    Lith, Sanne A. M. van
    Pruis, Ilanah J.
    Tolboom, Nelleke
    Snijders, Tom J.
    Henssen, Dylan
    ter Laan, Mark
    te Dorsthorst, Maarten
    Leenders, William P. J.
    Gotthardt, Martin
    Nagarajah, James
    Robe, Pierre A.
    Hamer, Philip De Witt
    Hendrikse, Harry
    Oprea-Lager, Daniela E.
    Yaqub, Maqsood
    Boellaard, Ronald
    Wesseling, Pieter
    Balvers, Rutger K.
    Verburg, Frederik A.
    Harteveld, Anita A.
    Smits, Marion
    van den Bent, Martin
    van Zanten, Sophie E. M. Veldhuijzen
    van de Giessen, Elsmarieke
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (10) : 1526 - 1531
  • [30] Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
    Sheikhbahaei, Sara
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Solnes, Lilja B.
    Javadi, Mehrbod S.
    Ross, Ashley E.
    Pienta, Kenneth J.
    Allaf, Mohamad E.
    Haberkorn, Uwe
    Pomper, Martin G.
    Gorin, Michael A.
    Rowe, Steven P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) : 2117 - 2136
12345